These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

910 related items for PubMed ID: 28071011

  • 1. The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age.
    Swora-Cwynar E, Kujawska-Łuczak M, Suliburska J, Reguła J, Kargulewicz A, Kręgielska-Narożna M, Marcinkowska E, Kanikowska A, Bielas M, Grzymisławski M, Bogdański P.
    Acta Sci Pol Technol Aliment; 2016; 15(2):213-220. PubMed ID: 28071011
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 3. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 4. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
    Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F.
    J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
    [Abstract] [Full Text] [Related]

  • 6. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S, Akhtar N, Ahmad J.
    Diabetes Metab Syndr; 2012 Apr; 6(4):207-11. PubMed ID: 23199540
    [Abstract] [Full Text] [Related]

  • 7. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 8. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.
    van Dam EW, Roelfsema F, Veldhuis JD, Hogendoorn S, Westenberg J, Helmerhorst FM, Frölich M, Krans HM, Meinders AE, Pijl H.
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E615-20. PubMed ID: 14678951
    [Abstract] [Full Text] [Related]

  • 9. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P, Janowska J, Semik-Grabarczyk E.
    Endokrynol Pol; 2008 Apr; 59(1):13-7. PubMed ID: 18335395
    [Abstract] [Full Text] [Related]

  • 10. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA, Khurana ML, Nisar S, Shah PA, Shah ZA, Kulshrestha B, Gupta N, Zargar MA, Wani TA, Mudasir S, Mir FA, Taing S.
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [Abstract] [Full Text] [Related]

  • 11. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
    Fux Otta C, Wior M, Iraci GS, Kaplan R, Torres D, Gaido MI, Wyse EP.
    Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
    [Abstract] [Full Text] [Related]

  • 12. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
    Ozata M, Oktenli C, Bingol N, Ozdemir IC.
    Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
    [Abstract] [Full Text] [Related]

  • 13. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
    Liu RB, Liu Y, Lv LQ, Xiao W, Gong C, Yue JX.
    Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
    [Abstract] [Full Text] [Related]

  • 14. Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Wiltgen D, Matos MC, Spritzer PM.
    Gynecol Endocrinol; 2011 Nov; 27(11):925-30. PubMed ID: 21627406
    [Abstract] [Full Text] [Related]

  • 15. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S, Ahangari R, Hozoori M, Mozaffari-Khosravi H, Fallahzadeh H, Nadjarzadeh A.
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 17. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Jan; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 18. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 19. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH, von Eye Corleta H, Capp E, Spritzer PM.
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [Abstract] [Full Text] [Related]

  • 20. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
    Mejia-Montilla J, Reyna-Villasmil E, Torres-Cepeda D, Santos-Bolívar J, Reyna-Villasmil N, Bravo-Henríquez A.
    Endocrinol Nutr; 2012 Jan; 59(1):21-7. PubMed ID: 22115703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.